LIUZZI, ANASTASIA
LIUZZI, ANASTASIA
Istituto di Biologia e Patologia Molecolari - IBPM
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.012 secondi).
UbC4 from Leishmania is a Druggable E2 Ubiquitin Conjugating Enzyme: Structural Basis and Fragment Hits for Future E2-Recruiting PROTAC Development
2026 Exertier, C.; Antonelli, L.; Liuzzi, A.; Ruffa, M.; Brufani, V.; Colotti, G.; Fiorillo, A.; Ilari, A.
Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery
2023 Espinozachavez, Rm; Salerno, A; Liuzzi, A; Ilari, A; Milelli, A; Uliassi, E; Bolognesi, Ml
Innovative Approach for a Classic Target: Fragment Screening on Trypanothione Reductase Reveals New Opportunities for Drug Design
2022 Fiorillo, A; Colotti, G; Exertier, C; Liuzzi, A; Seghetti, F; Salerno, A; Caciolla, J; Ilari, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| UbC4 from Leishmania is a Druggable E2 Ubiquitin Conjugating Enzyme: Structural Basis and Fragment Hits for Future E2-Recruiting PROTAC Development | 1-gen-2026 | Exertier, C.; Antonelli, L.; Liuzzi, A.; Ruffa, M.; Brufani, V.; Colotti, G.; Fiorillo, A.; Ilari, A. | |
| Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery | 1-gen-2023 | Espinozachavez, Rm; Salerno, A; Liuzzi, A; Ilari, A; Milelli, A; Uliassi, E; Bolognesi, Ml | |
| Innovative Approach for a Classic Target: Fragment Screening on Trypanothione Reductase Reveals New Opportunities for Drug Design | 1-gen-2022 | Fiorillo, A; Colotti, G; Exertier, C; Liuzzi, A; Seghetti, F; Salerno, A; Caciolla, J; Ilari, A |